Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Consolidated Net Profit

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATH BIOGENES (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Consolidated Net Profit ₹39 Cr₹40 Cr₹35 Cr₹-67 Cr₹12 Cr

What is the latest Consolidated Net Profit of NATH BIOGENES (INDIA) ?

The latest Consolidated Net Profit ratio of NATH BIOGENES (INDIA) is ₹39 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹39 Cr
Mar2024₹40 Cr
Mar2023₹35 Cr
Mar2022₹-67 Cr
Mar2013₹12 Cr

How is Consolidated Net Profit of NATH BIOGENES (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹39 Cr
-2.57
Mar2024 ₹40 Cr
13.11
Mar2023 ₹35 Cr
Positive
Mar2022 ₹-67 Cr
Negative
Mar2013 ₹12 Cr -

Compare Consolidated Net Profit of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹270.9 Cr 1.5% -4.6% -6.5% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,634.6 Cr -0.8% -17.7% -12.5% Stock Analytics
KAVERI SEED COMPANY ₹4,168.6 Cr 5.6% -9.3% -24.5% Stock Analytics
VENKYS (INDIA) ₹1,709.7 Cr -4.1% -15.9% -24.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹861.0 Cr -1.6% -10.7% -38.2% Stock Analytics
INDO US BIOTECH ₹198.8 Cr -3.1% -24.8% -46.6% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

1.5%

-4.6%

-6.5%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses